Global Cryopreservation Equipment Market By Equipment(Freezers, Sample Preparation Systems, Incubators, Accessories, Other Equipments), By Cryogen(Liquid Nitrogen, Oxygen, Liquid Helium, Argon), By Application(Cord Blood Stem Cells, Semen & Testicular Tissues, Embryos & Oocytes, Other Applications), By End-User(Stem Cells Banks, Contract Research Organizations, Biotechnology & Pharmaceutical Organization, Research and Academic Institutes), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2024-2033

Report Overview

The Global Cryopreservation Equipment Market size is expected to be worth around USD 25.6 Billion by 2033, From USD 8.1 Billion by 2023, growing at a CAGR of 12.20% during the forecast period from 2024 to 2033.

The Cryopreservation Equipment Market encompasses an array of technologies and equipment designed for the preservation of biological samples, such as cells, tissues, and organs, at extremely low temperatures. This market’s significance is underscored by its critical role in biomedical research, regenerative medicine, and fertility services, facilitating long-term storage with minimal degradation.

Key components include freezers, storage systems, cryogenic tanks, and software solutions, catering to the demands of biobanks, healthcare institutions, and research laboratories. The market’s expansion is driven by advancements in cryogenic technology, rising demand for biopreservation, and the growing investment in healthcare infrastructure, positioning it as a pivotal sector for stakeholders in the biomedical and healthcare industries.

The Cryopreservation Equipment Market is undergoing significant transformations, driven by the increasing demand for biopreservation for applications in medical research, regenerative medicine, and biobanking. The pivotal role of cryopreservation in extending the shelf life of biological samples, such as cells, tissues, and organs, underpins its importance in the biomedical and healthcare sectors. The employment of bioengineers and biomedical engineers, critical to the development and optimization of cryopreservation techniques and equipment, is projected to grow by 5% from 2022 to 2032. This growth reflects the expanding scope of biotechnology applications and the need for sophisticated cryopreservation solutions to support them.

However, the market faces challenges, underscored by the occurrence of at least nine major tank failures in the United States over the past 15 years, affecting more than 1,000 individuals. These incidents highlight the imperative for advancements in equipment reliability and the establishment of more stringent industry standards. The integration of cutting-edge technologies, such as artificial intelligence and IoT, for monitoring and maintaining optimal conditions in cryogenic storage, is anticipated to address these concerns and drive market growth.

As the market evolves, stakeholders must navigate both opportunities and obstacles. The anticipated expansion in the employment of bioengineering professionals suggests a positive trajectory for innovation and market development. Nonetheless, the historical incidences of equipment failure call for reevaluating current practices and adopting enhanced safety and quality protocols.

Key Takeaways

• Market Growth: Global Cryopreservation Equipment Market size is expected to be worth around USD 25.6 Billion by 2033, From USD 8.1 Billion by 2023, growing at a CAGR of 12.20% during the forecast period from 2024 to 2033.
• Regional Dominance: North America dominates the Cryopreservation Equipment Market with a commanding 37% market share.
  
• Segmentation Insights:
  • By Equipment: The market share held by freezers in the equipment segment stands at 37%.
  • By Cryogen: Liquid nitrogen commands a 34% market share in the cryogen category.
  • By Application: In the application segment, semen and testicular tissues represent a 41% market share.
  • By End-User: Research and Academic Institutes, as end-users, dominate with a 46% market share.
• Growth Opportunities: In 2023, the Cryopreservation Equipment Market flourished due to the rising adoption of ART, fueled by infertility rates. Investments in healthcare and research drove demand, fostering innovation and market expansion.
  

Driving Factors

Surge in Biological Sample Preservation Demand

The Cryopreservation Equipment Market is experiencing substantial growth, primarily driven by the increasing need for preserving biological samples, including cells, tissues, and organs. This surge in demand can be attributed to the expanding applications in medical research, regenerative medicine, and biobanking. As the healthcare and pharmaceutical industries continue to advance, the requirement for high-quality biological samples for drug development, disease research, and personalized medicine intensifies.

Consequently, the utilization of cryopreservation equipment becomes essential for maintaining the integrity and viability of these biological specimens over extended periods. Market data indicate that the biobanking sector, a significant consumer of cryopreservation solutions, is projected to witness considerable expansion, further propelling the demand for efficient cryopreservation equipment. This trend underscores the critical role of cryopreservation in supporting the foundational needs of contemporary medical and scientific research.

Advancements in Stem Cell Cryopreservation Equipment

Parallelly, the Cryopreservation Equipment Market is benefiting from technological advancements in stem cell cryopreservation. These innovations enhance the efficiency and reliability of freezing and thawing procedures, thereby improving the survival rates of stem cells post-cryopreservation. Stem cells are pivotal in regenerative medicine and tissue engineering, offering potential cures for chronic diseases and conditions.

The refinement of cryopreservation equipment to ensure the maximal viability of stem cells extends the scope of their application, facilitating breakthroughs in medical treatments and therapies. The introduction of automated and programmable freezers, coupled with the development of advanced cryoprotectants, represents a leap forward in cryopreservation technology.

These advancements not only bolster the market growth by increasing the adoption of cryopreservation equipment in stem cell research but also promise to enhance the therapeutic outcomes of stem cell-based interventions. Market analyses forecast a significant uptick in investment in stem cell research, which is poised to drive further innovation and adoption of cutting-edge cryopreservation equipment in the sector.

Restraining Factors

Economic Constraints: High Cost of Equipment and Maintenance

The high cost of cryopreservation equipment and its maintenance stands as a significant economic barrier, directly impacting the market’s accessibility and growth potential. These financial constraints are particularly burdensome for smaller laboratories and research institutions, which might struggle to allocate sufficient budget for such capital-intensive investments.

The initial outlay for advanced cryopreservation systems, along with ongoing expenses related to their operation, maintenance, and the necessary consumables, can deter potential new entrants from adopting these technologies. Consequently, this factor restricts the market’s expansion by limiting its accessibility to a broader range of users.

Despite these challenges, the demand for cryopreservation in fields such as regenerative medicine, biobanking, and pharmaceuticals continues to grow, suggesting a latent market potential that could be unlocked with cost-reduction strategies and the development of more affordable equipment solutions.

Technical Barriers: Complexity of the Cryopreservation Process

The intricacy of cryopreservation procedures presents a substantial technical barrier, influencing the market’s growth trajectory. This complexity requires highly skilled personnel and rigorous protocol adherence to ensure the viability and integrity of biological samples. The steep learning curve and the need for specialized training can impede the adoption of cryopreservation technologies, particularly in emerging markets and among institutions with limited resources.

Additionally, the variability in sample types and the requirement for precise temperature control and cryoprotectant usage complicate the process further, demanding a high level of expertise and sophisticated equipment. These technical challenges not only increase operational costs but also elevate the risk of sample loss or degradation, affecting the reliability and efficiency of cryopreservation efforts.

Addressing these complexities through innovation in equipment design, simplification of processes, and enhanced training programs could mitigate these barriers, facilitating broader market penetration and supporting growth in the cryopreservation equipment sector.

By Equipment Analysis

In the equipment segment of the market, freezers hold a significant share, accounting for 37% of the total market.

In 2023, the Cryopreservation Equipment Market was characterized by several key segments, prominently including Freezers, Sample Preparation Systems, Incubators, Accessories, and Other Equipment. Among these, Freezers held a dominant market position in the By Equipment segment, capturing more than a 37% share. This significant market share can be attributed to the crucial role freezers play in the long-term storage of biological samples, including cells, tissues, and organs, across various applications in biomedical research, pharmaceuticals, and medical procedures.

The importance of Sample Preparation Systems also cannot be understated, as these systems facilitate the processing of samples for cryopreservation, ensuring viability and integrity post-thaw. Incubators, essential for controlled environment conditions, support the preparatory and recovery phases of cryopreservation, influencing the market with their indispensable utility in research and clinical settings.

Accessories, encompassing a range of supplementary items such as cryovials, gloves, and protective eyewear, play a supportive yet vital role in the operational efficiency and safety of cryopreservation processes. The category of Other Equipment, which includes specialized tools and devices for specific cryopreservation needs, further underscores the market’s diversity and the evolving demand for innovative solutions.

This segmentation reflects the market’s complexity and the diverse requirements of end-users in the cryopreservation equipment landscape. The dominant position of freezers highlights the foundational need for reliable long-term storage solutions, while the significance of other segments underscores the comprehensive nature of cryopreservation practices in supporting biomedical research and healthcare advancements.

By Cryogen Analysis

Within the cryogen category, liquid nitrogen emerges as a dominant choice, securing a 34% share of the market.

In 2023, the Cryopreservation Equipment Market experienced significant trends across its Cryogen segment, with Liquid Nitrogen, Oxygen, Liquid Helium, and Argon being the primary cryogens utilized. Among these, Liquid Nitrogen held a dominant market position, capturing more than a 34% share. This prominence can be attributed to its extensive application in biological sample preservation due to its low boiling point and non-reactive nature, making it an indispensable resource in medical, pharmaceutical, and biotechnological research and applications.

Oxygen, while essential in various industrial and medical applications, held a lesser share in the cryopreservation market due to its reactive properties and specific application requirements. Liquid Helium, despite its lower boiling point compared to Liquid Nitrogen, which makes it suitable for ultra-low temperature applications, is limited by its higher cost and relatively scarce availability. Argon, being inert like Liquid Nitrogen, found its application in cryopreservation, albeit to a smaller extent due to its denser nature and specific use cases in the sector.

The growth of the Cryopreservation Equipment Market, particularly the By Cryogen segment, is driven by the increasing demand for cryogenic storage systems in the healthcare sector, including the preservation of stem cells, blood, and other biological samples. Advances in cryogenic technology, alongside the expanding applications in life sciences research, further bolster the market’s expansion. The strategic positioning of Liquid Nitrogen as the leading cryogen underscores its pivotal role in meeting the critical storage requirements of modern medical and scientific endeavors.

By Application Analysis

Focusing on applications, semen, and testicular tissues command a notable 41% market share, reflecting their importance.

In 2023, the Cryopreservation Equipment Market witnessed a significant segmentation by application, with Cord Blood Stem Cells, Semen & Testicular Tissues, Embryos & Oocytes, and Other Applications as the primary categories. Among these, Semen & Testicular Tissues held a dominant market position, capturing more than a 41% share. This substantial market share can be attributed to the increasing demand for reproductive and fertility services, coupled with advancements in cryopreservation techniques that have enhanced the viability and success rates of preserved samples.

The Cord Blood Stem Cells segment also represented a significant portion of the market, driven by the growing recognition of its potential in treating a range of genetic and hematopoietic disorders. The preservation of Embryos & Oocytes is gaining traction, reflecting societal shifts towards later parenting and the rising prevalence of fertility issues, thereby necessitating the need for advanced cryopreservation solutions.

Other Applications, encompassing a variety of biological samples and tissues, underscore the broad applicability and versatility of cryopreservation equipment in contemporary medical science and research.

The dominance of Semen & Testicular Tissues in the Cryopreservation Equipment Market underscores the evolving landscape of reproductive health services and the critical role of cryopreservation in facilitating these advancements. The market’s growth is further supported by continuous technological innovations, increasing accessibility to fertility treatments, and the rising awareness of cryopreservation as a viable option for prolonging fertility and preserving genetic materials.

By End-User Analysis

Research and Academic Institutes stand out as the primary end-users, holding a dominant 46% share of the market.

In 2023, Research and Academic Institutes emerged as the leading end-users in the Cryopreservation Equipment Market, commanding a substantial market share of over 46%. This notable dominance can be attributed to the escalating demand for cryopreservation technologies within academic and research settings, driven by the need to preserve biological samples, including cells, tissues, and organs, for prolonged periods. The application of cryopreservation equipment in these institutes is critical for advancing research in various fields such as regenerative medicine, drug discovery, and cellular therapies.

The proliferation of research activities, coupled with significant advancements in biobanking practices, has further reinforced the position of Research and Academic Institutes at the forefront of this market segment. The integration of state-of-the-art cryopreservation techniques enables these institutions to enhance the viability and integrity of biological specimens, thereby facilitating groundbreaking scientific discoveries and innovations.

Moreover, the increasing investments in research and development activities by governments and private entities worldwide have contributed to the expansion of the cryopreservation equipment market within this segment. This financial backing not only supports the acquisition of advanced cryopreservation systems but also fosters the development of innovative preservation solutions tailored to meet the intricate requirements of research and academic endeavors.

The strategic focus on biopreservation by Research and Academic Institutes is anticipated to continue driving the growth of the Cryopreservation Equipment Market. As these institutions seek to optimize their research capabilities and extend the lifespan of critical biological samples, the demand for efficient and reliable cryopreservation solutions is expected to escalate, further cementing their dominant market position.

Key Market Segments

By Equipment

• Freezers
• Sample Preparation Systems
• Incubators
• Accessories
• Other Equipments

By Cryogen

• Liquid Nitrogen
• Oxygen
• Liquid Helium
• Argon

By Application

• Cord Blood Stem Cells
• Semen & Testicular Tissues
• Embryos & Oocytes
• Other Applications

By End-User

• Stem Cells Banks
• Contract Research Organizations
• Biotechnology & Pharmaceutical Organization
• Research and Academic Institutes

Growth Opportunities

Growing Adoption of Cryopreservation Techniques in Assisted Reproductive Technology (ART)

The global Cryopreservation Equipment Market witnessed substantial growth opportunities in 2023, primarily fueled by the increasing adoption of cryopreservation techniques in Assisted Reproductive Technology (ART) procedures, notably in vitro fertilization (IVF). The burgeoning demand for ART procedures, coupled with advancements in cryopreservation technology, has propelled market expansion.

Cryopreservation plays a pivotal role in preserving gametes, embryos, and reproductive tissues, enhancing the success rates of ART treatments. As infertility rates continue to rise globally, the utilization of cryopreservation in ART procedures is poised to surge, presenting lucrative opportunities for market players.

Increasing Investments in Healthcare Infrastructure and Life Sciences Research

In 2023, the global Cryopreservation Equipment Market experienced significant growth prospects attributed to escalating investments in healthcare infrastructure and life sciences research. Governments and private stakeholders worldwide are allocating substantial funds towards upgrading healthcare facilities and bolstering research initiatives, fostering the demand for cryopreservation equipment.

Moreover, the growing emphasis on regenerative medicine and stem cell therapies has propelled the need for advanced cryopreservation solutions to preserve biological materials effectively. This influx of investments has spurred innovation and technological advancements in cryopreservation equipment, driving market growth.

Latest Trends

Expansion of Biopharmaceutical Research

The expansion of biopharmaceutical research is expected to drive the demand for cryopreservation equipment in the global market. Biopharmaceutical companies are increasingly focusing on the development of innovative therapies such as cell and gene therapies, monoclonal antibodies, and vaccines. These therapies often require the cryopreservation of biological materials, including cells, tissues, and stem cells, for long-term storage and transportation.

As biopharmaceutical research continues to advance, there is a growing need for cryopreservation equipment that can meet the specialized requirements of these therapies. Manufacturers are investing in the development of advanced cryopreservation technologies, such as automated systems with precise temperature control and monitoring capabilities, to support the growing demands of the biopharmaceutical industry.

Growing Awareness about Cord Blood Banking

There is a growing awareness about the importance of cord blood banking, which involves the collection and cryopreservation of stem cells from the umbilical cord blood of newborn babies. Cord blood stem cells can potentially treat various diseases and disorders, including leukemia, lymphoma, and certain genetic disorders. As a result, an increasing number of parents are opting to bank their baby’s cord blood for potential future use.

This trend is driving the demand for cryopreservation equipment in the global market, as cord blood banks require specialized equipment to collect, process, and store cord blood units. Manufacturers are developing cryopreservation systems that are specifically designed for cord blood banking applications, with features such as automated processing, controlled-rate freezing, and long-term storage capabilities.

Regional Analysis

With a 37% market share in North America, the Cryopreservation Equipment Market demonstrates significant prominence and competitiveness in the region.

The cryopreservation equipment market exhibits notable regional disparities, with North America emerging as the dominant player, capturing a substantial market share of 37%. In North America, the robust presence of key industry players coupled with significant investments in research and development initiatives propels market growth. Moreover, the increasing prevalence of chronic diseases and the rising demand for organ transplantation procedures contribute to the expansion of cryopreservation equipment adoption across the region.

In Europe, stringent regulations governing the storage and transportation of biological samples drive the demand for advanced cryopreservation solutions. The region accounts for a considerable portion of the market share, supported by the growing focus on personalized medicine and regenerative therapies.

Asia Pacific demonstrates immense growth potential, fueled by expanding healthcare infrastructure, rising healthcare expenditure, and the growing awareness regarding the benefits of cryopreservation techniques. Furthermore, government initiatives aimed at improving healthcare access and the presence of untapped markets amplify market prospects in the region.

The Middle East & Africa and Latin America regions are witnessing gradual market growth, attributed to the increasing adoption of cryopreservation technologies in research and clinical applications. Despite facing challenges related to infrastructure development and economic constraints, these regions are expected to witness steady growth due to ongoing advancements in healthcare systems and rising investments in biotechnology research.

Key Regions and Countries

• North America
  • The US
  • Canada
  • Mexico
• Western Europe
  • Germany
  • France
  • The UK
  • Spain
  • Italy
  • Portugal
  • Ireland
  • Austria
  • Switzerland
  • Benelux
  • Nordic
  • Rest of Western Europe
• Eastern Europe
  • Russia
  • Poland
  • The Czech Republic
  • Greece
  • Rest of Eastern Europe
• APAC
  • China
  • Japan
  • South Korea
  • India
  • Australia & New Zealand
  • Indonesia
  • Malaysia
  • Philippines
  • Singapore
  • Thailand
  • Vietnam
  • Rest of APAC
• Latin America
  • Brazil
  • Colombia
  • Chile
  • Argentina
  • Costa Rica
  • Rest of Latin America
• Middle East & Africa
  • Algeria
  • Egypt
  • Israel
  • Kuwait
  • Nigeria
  • Saudi Arabia
  • South Africa
  • Turkey
  • United Arab Emirates
  • Rest of MEA

Key Players Analysis

In the landscape of the global Cryopreservation Equipment Market in 2023, several key players have emerged as pivotal entities shaping the industry’s trajectory. Among these, companies such as Charter Medicals, Thermo Fisher Scientific Inc., Cryogenic Control, and Merck KGaA stand out prominently. Their influence extends beyond mere market presence; they serve as vanguards of innovation and reliability within the cryopreservation sector.

Charter Medicals, with its commitment to cutting-edge technology and quality assurance, sets a benchmark for excellence in cryopreservation equipment. Meanwhile, Thermo Fisher Scientific Inc. leverages its extensive R&D capabilities to develop advanced solutions that cater to the evolving needs of the market. Cryogenic Control’s specialized offerings and Merck KGaA’s global reach further bolster the competitive landscape, fostering a culture of continual improvement and expansion.

Additionally, companies like Chart Biomedical Co. Ltd., Praxair Technology Inc., and Custom Biogenic Systems Cryologic Pty. Ltd. contribute significantly to the market’s dynamics. Their diverse product portfolios and strategic initiatives enhance market competitiveness while addressing specific customer demands across various segments.

Furthermore, Linde LLC., Haimen United Laboratory Equipment Development Co., Ltd., and BarberNichols Inc. bring their expertise and resources to the table, enriching the cryopreservation ecosystem with innovative solutions and exceptional service standards.

In essence, these key players collectively drive the growth and innovation within the global Cryopreservation Equipment Market in 2023. Their relentless pursuit of excellence, coupled with a deep understanding of market dynamics, positions them as cornerstones of the industry, poised to shape its future trajectory with unwavering confidence and expertise.

Market Key Players

• Charter Medicals
• Thermo Fisher Scientific Inc.
• Cryogenic Control
• Merck KGaA
• Chart Biomedical Co. Ltd.
• Praxair Technology Inc.
• Custom Biogenic Systems Cryologic Pty. Ltd.
• Linde LLC.
• Haimen United Laboratory Equipment Development Co., Ltd.
• BarberNichols Inc

Recent Development

• In November 2023, The UQ Centre for Horticultural Science, led by Alice Hayward, pioneers cryopreservation to safeguard Myrtaceae species endangered by myrtle rust, partnering with the Australian PlantBank for protocol development.
• In October 2023, Cellipont Bioservices and Evia Bio partnered to launch the Cryopreservation Excellence Center (CryoX) in Houston, TX. CryoX aims to enhance the cold supply chain for global cell therapy with hands-on training and collaboration opportunities.
• In August 2023, Researchers at Texas A&M University developed a field-ready cryopreservation technique for coral fragments, aiding in their revival and long-term survival, addressing the global reef crisis. Published in Nature.
• In August 2023, Researchers at the University of Surrey and the University of Warwick are pioneering innovative cryopreservation techniques to address challenges in biomedical research, including improving cell-based therapies and organ transplantation.

Report Scope